Mirjam K Rommers
Affiliation: Leiden University Medical Center
Country: The Netherlands
- Preventing adverse drug events in hospital practice: an overviewMirjam K Rommers
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, The Netherlands
Pharmacoepidemiol Drug Saf 16:1129-35. 2007..Moreover, two promising CDSS are discussed in more detail, namely computer-based monitoring systems and information systems which link laboratory and pharmacy data...
- A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the NetherlandsMirjam K Rommers
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands
Drug Saf 34:233-42. 2011..In the Netherlands there are some basic CDSS within CPOE systems, but there is not much experience with sophisticated systems. We have recently developed a more advanced CDSS, a computerized adverse drug event alerting system (ADEAS)...
- Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot studyMirjam K Rommers
Hospital Pharmacy Midden Brabant TweeSteden Hospital and St Elisabeth Hospital, Tilburg, The Netherlands
Crit Care 10:R93. 2006..The objective of this study is to compare the anti-Xa activity of dalteparin after subcutaneous administration in ICU patients with and without subcutaneous oedema...
- Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug eventM K Rommers
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
Qual Saf Health Care 19:e35. 2010..Fortunately, a substantial part of ADEs is preventable, and computerised physician order entry with a sophisticated clinical decision support system may be used to reach this goal...